We are live on ! Find out more
MAM

Marquette Asset Management Portfolio holdings

AUM $779M
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+23.4%
3 Year Est. Return
+63.51%
5 Year Est. Return
+57.16%
10 Year Est. Return
+244.82%
AUM
$403M
AUM Growth
+$26.7M
Cap. Flow
+$5.12M
Cap. Flow %
1.27%
Top 10 Hldgs %
76.76%
Holding
308
New
95
Increased
36
Reduced
38
Closed
10
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPRB
101
Spruce Biosciences
SPRB
$127M
$120K 0.03%
743
HON icon
102
Honeywell
HON
$78.9B
$118K 0.03%
605
LTCH
103
DELISTED
Latch, Inc. Common Stock
LTCH
$118K 0.03%
84,809
-66,606
-44% -$62.2K
NUVB icon
104
Nuvation Bio
NUVB
$2.24B
$118K 0.03%
+65,390
New +$111K
SERA icon
105
Sera Prognostics
SERA
$75.6M
$118K 0.03%
35,687
-14,845
-29% -$50.9K
TMO icon
106
Thermo Fisher Scientific
TMO
$209B
$117K 0.03%
225
+25
+13% +$13.5K
KRON
107
DELISTED
Kronos Bio
KRON
$117K 0.03%
68,041
+19,484
+40% +$30.9K
AXR icon
108
AMREP Corp
AXR
$121M
$116K 0.03%
6,484
-5,978
-48% -$90.2K
XEL icon
109
Xcel Energy
XEL
$48.6B
$116K 0.03%
1,862
+400
+27% +$26.7K
CMRX
110
DELISTED
Chimerix, Inc.
CMRX
$114K 0.03%
+94,582
New +$120K
OMIC
111
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$114K 0.03%
4,564
+3,347
+275% +$98.1K
FLG
112
Flagstar Bank National Association
FLG
$5.95B
$112K 0.03%
3,333
PEP icon
113
PepsiCo
PEP
$190B
$111K 0.03%
600
LENZ
114
LENZ Therapeutics
LENZ
$158M
$107K 0.03%
5,866
CRL icon
115
Charles River Laboratories
CRL
$11.3B
$104K 0.03%
497
RFL icon
116
Rafael Holdings
RFL
$97.2M
$103K 0.03%
49,946
LUMO
117
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$103K 0.03%
31,088
SPYG icon
118
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.2B
$100K 0.02%
1,640
PRDS
119
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$98.2K 0.02%
+54,278
New +$99.2K
BNDX icon
120
Vanguard Total International Bond ETF
BNDX
$82.3B
$95.7K 0.02%
1,957
USB icon
121
US Bancorp
USB
$100B
$93.5K 0.02%
2,830
AVIR icon
122
Atea Pharmaceuticals
AVIR
$376M
$93K 0.02%
24,865
SHPW
123
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$92.5K 0.02%
24,610
-8,485
-26% -$26.4K
CKX icon
124
CKX Lands
CKX
$22.2M
$92.3K 0.02%
9,240
COO icon
125
Cooper Companies
COO
$14.6B
$92K 0.02%
960

Similar funds

Marquette Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Marquette Asset Management held 308 positions worth $403M, up 7.1% from $376M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Marquette Asset Management's Q2 2023 filing shows 95 new, 36 increased, 38 reduced and 10 closed positions. Its largest new stake was Seneca Foods Class A: 8,807 shares worth $288K. The largest sale was Schwab US Large-Cap Growth ETF, an estimated $1.12M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 1.6% of assets, down from 1.7% a quarter earlier, followed by Healthcare and Technology.

  • Marquette Asset Management's largest Q2 2023 buy was Seneca Foods Class A: 8,807 shares worth $288K.
  • Marquette Asset Management added most to Dimensional International Core Equity Market ETF in Q2 2023, an estimated $3.61M increase.
  • Marquette Asset Management's biggest Q2 2023 reduction was Schwab US Large-Cap Growth ETF, cutting an estimated $1.12M.
  • Marquette Asset Management fully exited TAT Technologies in Q2 2023, selling an estimated $243K.
  • Marquette Asset Management's ten largest holdings make up 77% of its $403M portfolio in Q2 2023.
  • Marquette Asset Management opened 95 new positions and closed 10 in Q2 2023.
  • Marquette Asset Management's portfolio value rose 7.1% quarter-over-quarter to $403M.

Based on Marquette Asset Management's 13F filing for Q2 2023, filed 28 Jul 2023.